Does BIMEKIZUMAB Cause Nasopharyngitis? 69 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Nasopharyngitis have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 2.8% of all adverse event reports for BIMEKIZUMAB.
69
Reports of Nasopharyngitis with BIMEKIZUMAB
2.8%
of all BIMEKIZUMAB reports
0
Deaths
20
Hospitalizations
How Dangerous Is Nasopharyngitis From BIMEKIZUMAB?
Of the 69 reports, 20 (29.0%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for BIMEKIZUMAB.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which BIMEKIZUMAB Alternatives Have Lower Nasopharyngitis Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN